OIRA Conclusion of EO 12866 Regulatory Review
RIN: 0906-AB04 View EO 12866 Meetings | Received Date: 04/09/2014 |
Title: 340B Drug Pricing Program Regulations | |
Agency/Subagency: HHS / HRSA | |
Concluded Action: Withdrawn | Concluded Date: 11/13/2014 |
Publication Date: | |
Regulatory Flexibility Analysis Required: No | Small Entities Affected: No |
Federalism Implications: No | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
International Impacts: No | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
Pandemic Response: Uncollected | |
|